(Q28194925)

English

Clinical impact of a pharmacist-managed diabetes mellitus drug therapy management service

scientific article (publication date: February 2006)

In more languages

edit

Statements

instance of

scholarly article

0 references

title

Clinical impact of a pharmacist-managed diabetes mellitus drug therapy management service (English)

0 references

author name string

Amie D McCord

series ordinal

1

0 references

language of work or name

English

0 references

publication date

February 2006

0 references

published in

Pharmacotherapy

0 references

volume

26

0 references

issue

2

0 references

page(s)

248-53

0 references

cites work

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1592/PHCO.26.2.248

retrieved

21 April 2017

Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1592/PHCO.26.2.248

retrieved

21 April 2017

Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1592/PHCO.26.2.248

retrieved

21 April 2017

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1592/PHCO.26.2.248

retrieved

21 April 2017

Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1592%2FPHCO.26.2.248

retrieved

21 April 2017

Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1592%2FPHCO.26.2.248

retrieved

21 April 2017

Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1592%2FPHCO.26.2.248

retrieved

21 April 2017

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1592%2FPHCO.26.2.248

retrieved

21 January 2018

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1592%2FPHCO.26.2.248

retrieved

21 January 2018

Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1592%2FPHCO.26.2.248

retrieved

21 January 2018

Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1592%2FPHCO.26.2.248

retrieved

21 January 2018

Attitudes and behaviors of primary care physicians regarding tight control of blood glucose in IDDM patients.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1592%2FPHCO.26.2.248

retrieved

21 January 2018

Population-based assessment of the level of care among adults with diabetes in the U.S.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1592%2FPHCO.26.2.248

retrieved

21 January 2018

A systematic approach to risk stratification and intervention within a managed care environment improves diabetes outcomes and patient satisfaction

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1592%2FPHCO.26.2.248

retrieved

21 January 2018

The effectiveness of disease and case management for people with diabetes. A systematic review

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1592%2FPHCO.26.2.248

retrieved

21 January 2018

Management of patients with type 2 diabetes by pharmacists in primary care clinics

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1592%2FPHCO.26.2.248

retrieved

21 January 2018

Effect of improved glycemic control on health care costs and utilization

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1592%2FPHCO.26.2.248

retrieved

21 January 2018

Identifiers

DOI

10.1592/PHCO.26.2.248

0 references

PubMed publication ID

16466329

0 references

ResearchGate publication ID

7308746

0 references

(Q28194925)

Clinical impact of a pharmacist-managed diabetes mellitus drug therapy management service

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)